De-Escalation and Discontinuation of Biologics in IBD: What to Consider
Although the definition of remission varies, the goal of IBD treatment is to achieve and sustain remission.
Gastrohepatic Disorders
Treatment Success Seen With Antibiotics for Uncomplicated Appendicitis
Seven days of oral antibiotics noninferior to two days of intravenous followed by oral antibiotics
Clinical Remission Observed With Risankizumab in Crohn Disease Trials
Risankizumab is currently FDA-approved under the brand name Skyrizi for the treatment of moderate to severe plaque psoriasis.
Sutab Tablets Now Available for Colonoscopy Prep
The product is administered as a split-dose regimen consisting of 2 doses.
MPR Weekly Dose Podcast Episode 62
Its been a long year, but the monumental efforts to achieve a COVID-19 vaccine are bearing some fruits, we about that, and also a fully at home diagnostic COVID test, as well as new findings related to glucosamine supplements and a novel treatment for eosinophilic esophagitis. And as ever, one final movie trivia ‘guess the quote’ to end the year!
FDA Approves Oxlumo for Primary Hyperoxaluria Type 1
Lumasiran is an investigational ribonucleic acid interference therapeutic that inhibits hepatic production of oxalate by targeting hydroxyacid oxidase 1.
FDA Approves Sulfate-Based Tablet Prep for Colonoscopy
Available as a sulfate-based tablet, Sutab provides an alternative to liquid-based colonoscopy preparations.
Most Users Report Cannabidiol Use for Treatment of Diagnosable Conditions
Psychiatric, orthopedic, and sleep issues most commonly cited in a Reddit forum
Management of Remdesivir-Associated Acute Liver Failure Examined in Case Series
Remdesivir was immediately discontinued in both patients and a continuous infusion of acetylcysteine was initiated.
ACS: Antibiotics Noninferior to Appendectomy for Appendicitis
However, complications occurred more often in the antibiotics group than in the appendectomy group.
